3/24
10:43 am
alvo
Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.
3/24
10:17 am
alvo
Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.
Low
Report
Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.
3/21
07:13 am
alvo
Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".
Medium
Report
Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".
3/20
03:26 am
alvo
Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]
Low
Report
Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]
3/19
03:17 pm
alvo
Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/19
10:02 am
alvo
Alvotech Q4 Earnings Call Highlights [Yahoo! Finance]
Neutral
Report
Alvotech Q4 Earnings Call Highlights [Yahoo! Finance]
3/19
01:47 am
alvo
Alvotech reports Q4 results [Seeking Alpha]
Medium
Report
Alvotech reports Q4 results [Seeking Alpha]
3/18
06:15 pm
alvo
Alvotech Q4 2025 and Full Year 2025 Financial Results
Medium
Report
Alvotech Q4 2025 and Full Year 2025 Financial Results
3/4
03:32 am
alvo
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/4
03:00 am
alvo
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
2/23
08:00 pm
alvo
ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
Low
Report
ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
2/20
07:27 am
alvo
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
2/16
07:35 am
alvo
Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price Slump [Yahoo! Finance]
Neutral
Report
Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price Slump [Yahoo! Finance]
2/15
04:15 am
alvo
Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 [Yahoo! Finance]
Neutral
Report
Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 [Yahoo! Finance]
2/9
04:08 pm
alvo
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/9
02:16 pm
alvo
ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash
Low
Report
ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash
2/9
03:02 am
alvo
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
Low
Report
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
2/5
05:40 pm
alvo
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Medium
Report
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/5
08:22 am
alvo
Alvotech higher on positive data backing biosimilar to Takeda's Entyvio [Seeking Alpha]
Medium
Report
Alvotech higher on positive data backing biosimilar to Takeda's Entyvio [Seeking Alpha]
2/5
03:00 am
alvo
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Medium
Report
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
2/2
06:55 pm
alvo
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/2
03:12 am
alvo
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates [Yahoo! Finance]
Low
Report
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates [Yahoo! Finance]
2/2
03:00 am
alvo
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
Low
Report
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
1/30
06:29 pm
alvo
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
1/29
06:26 am
alvo
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg [Yahoo! Finance]
Low
Report
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg [Yahoo! Finance]